Here is a statement about President Obama’s new stem-cell funding policy:
But Monday’s executive order is less about pitting the promise of one type of stem cell against another’s. It is more about re-establishing the authority of science, of ensuring that any and every potentially useful avenue of research will be pursued to its end. As the President himself noted, the new policy will not guarantee stem-cell treatments for diabetes, Parkinson’s or Lou Gehrig’s disease. But it does guarantee a commitment to the kind of promising research that this Administration — and many in the scientific community — believe must be followed.
Did it come from a White House press release? A Center for American Progress email? Nope. It’s from Time magazine’s coverage of the president’s decision, presented as hard news.